Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea
· Delayed Price · Currency is KRW 6,870.00
-30.00 (-0.43%)
At close: May 2, 2025, 3:30 PM KST
Revenue by Product
Financial numbers in millions KRW.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Pharmaceutical | 71,318 |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Growth | 38.10% |
Log In |
Log In |
Log In |
Log In |
| Mining | - |
Log In |
Log In |
Log In |
Log In |
| Mining Growth | - |
Log In |
Log In |
Log In |
Log In |
| Cosmetics | - |
Log In |
Log In |
Log In |
Log In |
| Cosmetics Growth | - |
Log In |
Log In |
Log In |
Log In |
| Adjustment | - |
Log In |
Log In |
Log In |
Log In |
| Adjustment Growth | - |
Log In |
Log In |
Log In |
Log In |
| Product | - |
Log In |
Log In |
Log In |
Log In |
| Product Growth | - |
Log In |
Log In |
Log In |
Log In |
| Commodity | - |
Log In |
Log In |
Log In |
Log In |
| Commodity Growth | - |
Log In |
Log In |
Log In |
Log In |
| Interest Loan | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Financial numbers in millions KRW.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| South Korea | 68,514 |
Log In |
Log In |
Log In |
Log In |
| South Korea Growth | 25.43% |
Log In |
Log In |
Log In |
Log In |
| China | 886.35 |
Log In |
Log In |
Log In |
Log In |
| China Growth | 97.42% |
Log In |
Log In |
Log In |
Log In |
| Russia | 277.09 |
Log In |
Log In |
Log In |
Log In |
| Russia Growth | 27.08% |
Log In |
Log In |
Log In |
Log In |
| Japan | 264.12 |
Log In |
Log In |
Log In |
Log In |
| Japan Growth | -75.39% |
Log In |
Log In |
Log In |
Log In |
| Vietnam | 149.27 |
Log In |
Log In |
Log In |
Log In |
| Vietnam Growth | -53.85% |
Log In |
Log In |
Log In |
Log In |
| Other | 1,227 |
Log In |
Log In |
Log In |
Log In |
| Other Growth | -48.44% |
Log In |
Log In |
Log In |
Log In |